Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar WHOVPLLC (31.82) Submitted: 7/3/2012 11:24:40 PM : Outperform Start Price: $40.49 MRK Score: -3.97

The new Healthcare Legislation ratified by "The Supremes" will increase the demand for Healthcare by the population of the United States. All Healthcare providers will benefit -- Less, of course, the reality of Price Controls.

Still, however a Net Positive and gain for BIG Pharma including Merck.

WHOVenturePartners, LLC
05 July 2012

Featured Broker Partners


Advertisement